CONDENSED BALANCE SHEETS - USD ($)	Jun. 30, 2023	Sep. 30, 2022
Current assets:
Cash and cash equivalents	$ 5,135,070	$ 22,672,138
Prepaid expenses	462,848	762,063
Supplies used for R&D and manufacturing	2,109,978	2,001,715
Deposits	23,850	0
Total current assets	7,731,746	25,435,916
Finance lease right of use assets	9,583,440	10,937,797
Operating lease right of use assets	1,746,355	1,884,464
Property and equipment, net	10,674,725	11,889,029
Patent costs, net	183,074	212,201
Deposits	2,319,101	0
Supplies used for R&D and manufacturing	80,527	164,299
Total assets	32,318,968	50,523,706
Current liabilities:
Accounts payable	1,742,651	1,618,290
Accrued expenses	1,141,292	842,492
Due to employees	499,661	471,488
Finance lease obligation, current portion	1,718,038	1,560,553
Operating lease obligation, current portion	190,831	170,928
Total current liabilities	5,292,473	4,663,751
Finance lease obligations, net of current portion	10,406,939	11,721,368
Operating lease obligations, net of current portion	1,705,157	1,850,380
Other liabilities	125,000	125,000
Total liabilities	17,529,569	18,360,499
STOCKHOLDERS' EQUITY
Preferred stock, $.01 par value; 200,000 shares authorized; 0 shares issued and outstanding	0	0
Common stock, $.01 par value; 600,000,000 shares authorized; 44,748,437 and 43,448,317 shares issued and outstanding at June 30, 2023 and September 30, 2022, respectively	447,484	434,484
Additional paid-in capital	493,802,607	486,625,816
Accumulated deficit	(479,460,692)	(454,897,093)
Total stockholders' equity	14,789,399	32,163,207
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ 32,318,968	$ 50,523,706